
    
      PRIMARY OBJECTIVES:

      I. To evaluate the feasibility of 68-Ga RM2 PET/MRI for identification of estrogen receptor
      positive primary breast cancer and metastases

      OUTLINE:

      Patients receive 68-Ga-RM2 intravenously (IV) and after 45 minutes undergo PET/MRI over 30-60
      minutes.

      After completion of study, patients are followed up at 24-72 hours, and then for 12 months.
    
  